1-6 of 6
Elizabeth F. Krakow
Close
Sort by
Journal Articles

HA-1-targeted T cell receptor (TCR) T cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.

Elizabeth F. Krakow, Michelle Brault, Corinne Summers, Tanya M Cunningham, Melinda A Biernacki, R Graeme Black, Kyle Blake Woodward, Nicole Vartanian, Sami B Kanaan, Albert C Yeh, Robson G Dossa, Merav Bar, Ryan D. Cassaday, Ann Dahlberg, Brian G. Till, Andrew E Denker, Cecilia C.S. Yeung, Ted A. Gooley, David G Maloney, Stanley R. Riddell, Philip D Greenberg, Aude G Chapuis, Evan W Newell, Scott N Furlan, Marie Bleakley
Journal: Blood
Blood blood.2024024105.
https://doi.org/10.1182/blood.2024024105
Published: 2024
Includes: Supplemental data
Journal Articles

Effects of Severe Acute Graft-Versus-Host Disease on Quality of Life, Medical Comorbidities and Survival

Nahid Rashid, Albert Yeh, Marco Mielcarek, Masumi Ueda Oshima, Elizabeth F Krakow, Lynn E. Onstad, Laura Connelly-Smith, Phuong Vo, Stephanie J. Lee
Journal: Blood
Blood (2022) 140 (Supplement 1): 10552–10553.
https://doi.org/10.1182/blood-2022-167820
Published: 2022
Journal Articles

Pilot Trial of IFN-γ and Donor Lymphocyte Infusion to Treat Relapsed AML and MDS after Allogeneic Hematopoietic Stem Cell Transplantation

Sawa Ito, Elizabeth F Krakow, Kedwin Ventura, Amy Rodger, Emily Geramita, Erika Moore, Geoffrey R Hill, Warren D Shlomchik
Journal: Blood
Blood (2022) 140 (Supplement 1): 7678–7679.
https://doi.org/10.1182/blood-2022-157054
Published: 2022
Journal Articles

BMT CTN 1803: Haploidentical Natural Killer Cells (K-NK002) to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)

Sumithra Vasu, MDMBBS, Nelli Bejanyan, MD, Steven M Devine, MD, Elizabeth O. Hexner, MD MSTR, Brent Logan, PhD, Leo Luznik, MD, Brittany K. Ragon, MD, Andrew Sandler, MD, Elizabeth F Krakow, MDMSc, Michael Fitzgerald, Lorraine Tracey, PhD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-134408
Published: 2020
Journal Articles

Phase I Study of Adoptive Immunotherapy with HA-1-Specific CD8 + and CD4 + Memory T Cells for Children and Adults with Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Trial in Progress

Elizabeth F Krakow, MDMSc, Corinne Summers, MD, Ann Dahlberg, MD, Merav Bar, Melinda Ann Biernacki, Tanya Cunningham, MSc, Nicole Vartanian, MSc, Megan Hickner, RN, Colette Chaney, RN, Tsadik Habtetsion, PhD, Kyle Woodward, PhD, Robson Dossa, PhD, Michelle Brault, PhD, Marie Bleakley, MBBS MMSc PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
https://doi.org/10.1182/blood-2020-137726
Published: 2020
Journal Articles

Phase I Study of Non-Engrafting Allogeneic, Mismatched, Unmanipulated Peripheral Blood Mononuclear Cell Infusions to Treat Poor-Prognosis Acute Myeloid Leukemia

Elizabeth F Krakow, MD MSc, Julie Bergeron, MD, Silvy Lachance, MD, Denis-Claude Roy, MD, Jean-Sebastien Delisle, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2562.
https://doi.org/10.1182/blood.V126.23.2562.2562
Published: 2015